Specifications:

• Erlonat belongs to a class of medications called Kinase inhibitorsand contains erlotinib. It is used for the treatment of non-smallcell lung cancer and in combination with Gemcitabine, is used forthe treatment of pancreatic cancer which spreads to adjacenttissues of the body. The action mechanism of the medicine is asfollows: Functions by blocking the action of an abnormal protein toslow down the growth of cancer cells Supplied as: Available in 25mg, 100 mg & 150 mg tablets

Description:

Brand Name:	Erlonat 150mg
Contents:	Erlotinib 150mg
Form:	Tablets
Strength:	25mg, 100mg & 150mg
Manufactured By:	Natco Pharma
Packing:	Pack of 30 tablets

 

Erlonat belongs to a class of medications called Kinaseinhibitors and contains erlotinib. It is used for the treatment ofnon-small cell lung cancer and in combination with Gemcitabine, isused for the treatment of pancreatic cancer which spreads toadjacent tissues of the body. The action mechanism of the medicineis as follows:
Functions by blocking the action of an abnormal protein to slowdown the growth of cancer cells

Supplied as:
Available in 25 mg, 100 mg & 150 mg tablets

Dosage: 
Usually 150 mg tablet is administered, at least an hour before ortwo hours after the ingestion of food, for curing pancreaticnon-small cell lung cancer. Erlonat is usually given as 100 mgtablets, at least an hour before or two hours after the intake offood, for curing of pancreatic cancer, in combination withgemcitabine.